StockData
Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc. (LXRX) stock

LXRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3087% above fair value
$1.72−0.06 (-3.37%)

Close on Nov 18, 2026Market cap $765.32MP/E –Yield –

Lexicon Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lexicon Pharmaceuticals's price to book ratio was 4.8× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 1.1× to 6.6×, with a median of 3.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.8×+1.3
2025Dec 31, 20253.5×+2.3
2024Dec 31, 20241.2×−1.1
2023Dec 29, 20232.3×+0.2
2022Dec 30, 20222.1×−1.9
2021Dec 31, 20214.0×−0.3
2020Dec 31, 20204.3×+1.5
2019Dec 31, 20192.7×−45.5
2018Jul 31, 201848.3×+35.1
2017Dec 29, 201713.2×+5.2
2016Dec 30, 20168.0×+1.3
2015Dec 31, 20156.6×+0.6
2014Dec 31, 20146.0×+1.1
2013Dec 31, 20135.0×+1.0
2012Dec 31, 20123.9×–

More Lexicon Pharmaceuticals figures

See a number that looks wrong?